Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lakisha Moore

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Mammary Gland Biology and Neoplasia|April 5, 2011
TGFBR1 signaling and breast cancerLakisha Moore-Smith, Boris Pasche
The Surgical Clinics of North America|July 15, 2018
Future Developments in Neoadjuvant Therapy for Triple-Negative Breast CancerLakisha Moore-Smith, Andres Forero-Torres, Erica Stringer-Reasor
International Journal of Environmental Research and Public Health|May 19, 2006
Heavy metals stimulate human LINE-1 retrotranspositionShubha P Kale, Lakisha Moore, Prescott L Deininger, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 27, 2013
SMAD4 is a potential prognostic marker in human breast carcinomasNan-nan Liu, Yue Xi, Michael U Callaghan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Mammary Gland Biology and Neoplasia|April 5, 2011
TGFBR1 signaling and breast cancerLakisha Moore-Smith, Boris Pasche
The Surgical Clinics of North America|July 15, 2018
Future Developments in Neoadjuvant Therapy for Triple-Negative Breast CancerLakisha Moore-Smith, Andres Forero-Torres, Erica Stringer-Reasor
International Journal of Environmental Research and Public Health|May 19, 2006
Heavy metals stimulate human LINE-1 retrotranspositionShubha P Kale, Lakisha Moore, Prescott L Deininger, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 27, 2013
SMAD4 is a potential prognostic marker in human breast carcinomasNan-nan Liu, Yue Xi, Michael U Callaghan, et al.
Pageof 1